Multiscale models of pharmacological, immunological and neurostimulation treatments in Alzheimer's disease

Vassilis Cutsuridis*, Ahmed A. Moustafa

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

7 Citations (Scopus)

Abstract

The current study reviews computational models that embody a hypothesis and/or a theory of mechanisms of how AD impacts the brain and cognition as well as provide a critical analysis of strengths and weaknesses of these models. Existing models assume AD symptoms stem from abnormalities to cell structure, synaptic connections, neuro-chemicals, as well as other neural circuits and systems. We also discuss how mathematical formulation of the known biology of AD can help us understand AD symptoms and how pharmacological medications and neurostimulation therapies may work. Finally, we discuss general research directions that may improve future treatments of the disease.

Original languageEnglish
Pages (from-to)85-91
Number of pages7
JournalDrug Discovery Today: Disease Models
Volume19
DOIs
Publication statusPublished - 1 Feb 2016
Externally publishedYes

Fingerprint

Dive into the research topics of 'Multiscale models of pharmacological, immunological and neurostimulation treatments in Alzheimer's disease'. Together they form a unique fingerprint.

Cite this